LOS ANGELES (AP) — LOS ANGELES (AP) — Renovaro Biosciences Inc. (RENB) on Tuesday reported a loss of $9.2 million in its fiscal first quarter.
On a per-share basis, the Los Angeles-based company said it had a loss of 14 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RENB at https://www.zacks.com/ap/RENB
Advertisement